Weltweit kleinste Herzpumpe Impella ECP erhält „Breakthrough Device“ – Status von FDA
von , Uhr
DANVERS, Massachusetts, USA--(BUSINESS WIRE)--The U.S. Food and Drug Administration has granted breakthrough device designation to Abiomed’s Impella ECP expandable percutaneous heart pump.
